News

Business Insider8y
Aspyrian announces the presentation of clinical data of its investigational therapy RM-1929 demonstrating significant anti-cancer response in recurrent Head and Neck Cancer ...
RM-1929 is an investigational compound that is not approved for any use in any country. For more information on the clinical trial, please follow this link to the study record on ClinicalTrials ...
Hosted on MSN2mon
UP scientists aim to improve breast cancer treatment with compound found in sea
The cocktail of the compound renieramycin M (RM) and doxorubicin (Dox) "significantly shrank tumors in mice while reducing the toxicity commonly associated with chemotherapy drugs," the ...
Hosted on MSN2mon
All-female UP scientists aim to improve breast cancer treatment with compound found in sea
The cocktail of the compound renieramycin M (RM) and doxorubicin (Dox) "significantly shrank tumors in mice while reducing the toxicity commonly associated with chemotherapy drugs," the ...